Navigation Links
Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research
Date:4/3/2008

Long Term Development Agreement to Produce Reference Standard Reagents to

Advance Cancer Research

NEWARK, Del., April 3, 2008 /PRNewswire-FirstCall/ -- Strategic Diagnostics Inc. (Nasdaq: SDIX) -- a leader in providing advanced antibody products and services to the life sciences industry announced that it has been selected by Science Applications International Corporation - Frederick (SAIC-F), to develop monoclonal antibodies for the Proteomics Reagents & Resources component of the National Cancer Institute (NCI) Clinical Proteomic Technologies for Cancer initiative (CPTC). The goal of CPTC is to accelerate discovery and clinical research in cancer using an integrated approach that assesses and optimizes proteomic technology measurement capabilities and develops universally accepted metrics that identify and minimize experimental variability from run to run, instrument to instrument, and lab to lab. CPTC aims to achieve this through the optimization of existing platforms; developing innovative proteomic technologies and computational tools; and developing community reagents and resources. The Proteomic Reagents & Resources component will include SOPs, data, proteins, and well-characterized, high-quality antibodies whose performance characteristics will be conducted at an Antibody Characterization Laboratory at NCI-Frederick (NCI-F) that is part of NCI-F's Advanced Technology Program.

SDI was awarded the competitive contract to produce monoclonal antibodies that will serve as reference reagents for the scientific cancer community based on its technical strength, large-scale capacity, standardized processes, and fully integrated quality management system.

Matthew H. Knight, SDI's President and C
'/>"/>

SOURCE Strategic Diagnostics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities
2. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
3. Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug
4. RxElite Filling Critical Requirement for Strategic Partners in Asia, Europe, and Australia
5. Medline and 3M Agree to Strategic Partnership in Electrosurgery
6. Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
7. Neuralstem Inc. Announces Strategic Investment by Korean CJ CheilJedang Corporation
8. Siemens and National Jewish Medical and Research Center Form Strategic Alliance to Advance Shared Vision of Personalized Medicine
9. Immtech Appoints Blythe Weigh as Strategic Advisor
10. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
11. Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Drug Discovery Technologies - A Global Update of Market Trends & Opportunities ,,
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
...MPAIGN, Ill. Graphene, a single-atom-thick sheet ...oelectronics applications. Whether graphene actual...graphene is cut, say researchers at the University...attice of carbon atoms. While scientists have pred...s of the lattice would affect the material,s elect...
...ERICK, Ireland, Feb. 16 Copan Innovation Ltd., wh... manufacturer of collection and transport systems ... President of Business Development in the Pacific ...of directors at Copan Innovation Ltd. , , Bob Co... in senior management positions at several interna...
...-reviewed journal, Science, reports that advanced ...tween improved lipid profile and heart protection ... Cholesterol Test from Atherotech, Inc., Universi...ion between a rare gene mutation and heart protect...uld help in the development of heart disease risk-...
Other Biology Technology:Scientists prove graphene's edge structure affects electronic properties 2Copan Announces the Appointment of Bob Cooper as Vice President of Business Development in the Pacific Rim 2VAP Cholesterol Test Helps In Search For New Heart Disease Drugs 2VAP Cholesterol Test Helps In Search For New Heart Disease Drugs 3VAP Cholesterol Test Helps In Search For New Heart Disease Drugs 4
(Date:12/4/2009)The electroencephalogram (EEG) is widely used by physicians and scientists to study brain function and to diagnose neurological disorders. However, it has remained largely unknown whether the electrod
(Date:12/4/2009)Using a new mathematical model of heart cells, University of Iowa investigators have shown how activation of a critical enzyme, calmodulin kinase II (CaM kinase), disrupts the electrical activity of h
(Date:12/3/2009)WALL, N.J., Dec. 3 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced that a majority of its sha
Breaking Biology News(10 mins):How to read brain activity? 2U-Iowa study helps advance heart-related research 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Muscle Weakness Linked to Alzheimers Risk in Seniors 61076 1Muscle Weakness Linked to Alzheimers Risk in Seniors 61076 2MetricStream Enters into Agreement to Provide GRC Platform for Risk based Internal Audit Management to Lear Corporation 61074 1MetricStream Enters into Agreement to Provide GRC Platform for Risk based Internal Audit Management to Lear Corporation 61074 2NJHA Issues Hospital Visitor Guidelines to Help Prevent Flus Spread 61071 1
...eering collaboration among U.S., European and Aust...eek to identify genetic differences in the way peo...led by scientists at Duke University, investigator...V will share access to patient groups, called coho...ium is provided by the Center for HIV/AIDS Vaccine...
...lete vaccination of poultry flocks could make the ... worse, scientists at the Universities of Edinburg...even though the available vaccines are effective o...d unless almost all of a flock has been protected....rst to quantify how incomplete vaccination of floc...
...st comprehensive scientific study of tiger habitat...ercent less habitat than they were thought to a de... their historic range. , This landmark study, c...undation,s Save The Tiger Fund and produced by som... Wildlife Fund, Wildlife Conservation Society, the...
Other Biology News:CHAVI announces international search for genes affecting HIV response 2CHAVI announces international search for genes affecting HIV response 3Bird flu study highlights need to vaccinate flocks effectively 2New tiger report release: Tiger habitat down from just a decade ago 2
Anti-Human I-FABP Polyclonal Antibody, Unconjugated from Cell Sciences
ProPrep BAC 960 from Biotech Support Group
ProPrep BAC 960 from Biotech Support Group
Chicken Anti-Plants Thaumatin 2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: